OncoBay Clinical

OncoBay Clinical is a boutique CRO specializing in immuno-oncology/cell therapy, offering customized full-service CRO solutions for global pharmaceutical and biotechnology companies looking to enhance their immuno-oncology products or devices. As a wholly-owned subsidiary of Moffitt Cancer Center, OncoBay possesses scientific expertise, operational excellence, and integrated cell manufacturing capabilities to provide true end-to-end control. Built on a foundation focused on cell therapy, streamlined technical frameworks, a network of well-trained sites, and an experienced professional team, OncoBay is committed to achieving operational excellence from start to finish.